Hemilä Harri, Virtamo Jarmo, Albanes Demetrius, Kaprio Jaakko
Department of Public Health, PO Box 41, University of Helsinki, Helsinki, FIN-00014 Finland.
Chest. 2004 Feb;125(2):557-65. doi: 10.1378/chest.125.2.557.
Vitamin E and beta-carotene affect various measures of immune function and accordingly might influence the predisposition of humans to infections. However, only few controlled trials have tested this hypothesis.
To examine whether vitamin E or beta-carotene supplementation affects the risk of pneumonia in a controlled trial.
The Alpha-Tocopherol Beta-Carotene Cancer Prevention (ATBC) study, a randomized, double-blind, placebo-controlled trial that examined the effects of vitamin E, 50 mg/d, and beta-carotene, 20 mg/d, on lung cancer using a 2 x 2 factorial design. The trial was conducted in the general community in southwestern Finland in 1985 to 1993; the intervention lasted for 6.1 years (median). The hypothesis being tested in the present study was formulated after the trial was closed.
ATBC study cohort of 29,133 men aged 50 to 69 years, who smoked at least five cigarettes per day, at baseline.
The first occurrence of hospital-treated pneumonia was retrieved from the national hospital discharge register (898 cases).
Vitamin E supplementation had no overall effect on the incidence of pneumonia (relative risk [RR], 1.00; 95% confidence interval [CI], 0.88 to 1.14) nor had beta-carotene supplementation (RR, 0.98; 95% CI, 0.85 to 1.11). Nevertheless, the age of smoking initiation was a highly significant modifying factor. Among subjects who had initiated smoking at a later age (> or =21 years; n = 7,469 with 196 pneumonia cases), vitamin E supplementation decreased the risk of pneumonia (RR, 0.65; 95% CI, 0.49 to 0.86), whereas beta-carotene supplementation increased the risk (RR, 1.42; 95% CI, 1.07 to 1.89).
Data from this large controlled trial suggest that vitamin E and beta-carotene supplementation have no overall effect on the risk of hospital-treated pneumonia in older male smokers, but our subgroup finding that vitamin E seemed to benefit subjects who initiated smoking at a later age warrants further investigation.
维生素E和β-胡萝卜素会影响免疫功能的各项指标,因此可能会影响人类对感染的易感性。然而,仅有少数对照试验验证了这一假设。
在一项对照试验中,研究补充维生素E或β-胡萝卜素是否会影响肺炎风险。
α-生育酚β-胡萝卜素癌症预防(ATBC)研究,这是一项随机、双盲、安慰剂对照试验,采用2×2析因设计,研究每日50毫克维生素E和每日20毫克β-胡萝卜素对肺癌的影响。该试验于1985年至1993年在芬兰西南部的普通社区进行;干预持续了6.1年(中位数)。本研究中所检验的假设是在试验结束后提出的。
ATBC研究队列中的29133名50至69岁男性,他们在基线时每天至少吸5支烟。
从国家医院出院登记处获取首次因医院治疗的肺炎病例(898例)。
补充维生素E对肺炎发病率无总体影响(相对风险[RR]为1.00;95%置信区间[CI]为0.88至1.14),补充β-胡萝卜素也无影响(RR为0.98;95%CI为0.85至1.11)。然而,开始吸烟的年龄是一个非常显著的修正因素。在开始吸烟较晚(≥21岁;n = 7469,有196例肺炎病例)的受试者中,补充维生素E降低了肺炎风险(RR为0.65;95%CI为0.49至0.86),而补充β-胡萝卜素则增加了风险(RR为1.42;95%CI为1.07至1.89)。
这项大型对照试验的数据表明,补充维生素E和β-胡萝卜素对老年男性吸烟者因医院治疗的肺炎风险无总体影响,但我们在亚组中的发现,即维生素E似乎对开始吸烟较晚的受试者有益,这值得进一步研究。